Degenerative cervical disc disease is a primary clinical setting for this cage, used during anterior cervical discectomy and fusion when a surgeon selects titanium over PEEK for its direct bone-integration properties at the affected level. Procurement governance matters here as much as clinical fit: NHS spine units evaluating titanium cervical interbody options need this cage stocked reliably alongside matched anterior cervical plate components, which is where Medigear.UK's role as a stocking supplier matters to tender decisions and theatre list planning. k's role as a stocking supplier matters to tender decisions and theatre list planning.
Cases with concerns about PEEK non-union or subsidence form a second clinical setting, where general clinical literature on titanium's direct bone integration may lead a surgeon to consider a titanium alternative for a specific patient's anatomy or bone quality at the cervical level being treated.
Cervical myelopathy and radiculopathy represent a third clinical setting, where nerve root or spinal cord compression from degenerative or herniated disc material is addressed through discectomy, with this titanium cage restoring the resulting disc space and supporting fusion during recovery from the procedure and subsequent rehabilitation.
Revision anterior cervical surgery is another important clinical setting, where a surgeon may select a titanium cage as part of a revised construct, particularly where imaging suggests bone did not adequately integrate with a previous PEEK device at the operated level. Medigear.uk supports single or small-quantity ordering of this cage alongside the larger bulk distributor accounts it also serves, so a specialist clinic is not required to commit to trust-scale volumes to access it.
